REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ildong Pharm Co., Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Ildong Pharm Co., Ltd. Profile Updated: December 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Ildong Pharm Co., Ltd. is an enterprise in South Korea, with the main office in Seoul. It operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on August 01, 2016. Ildong Pharm Co., Ltd. currently employs 1,014 (2024) people. The latest financial highlights indicate a net sales revenue drop of 8.56% in Q3C2025. During that time, Ildong Pharm Co., Ltd.’s total assets decreased by 2.81%.

Headquarters
2, Baumoi-Ro 27-Gil, Seocho-Gu
Seoul; Seoul;

Contact Details: Purchase the Ildong Pharm Co., Ltd. report to view the information.

Website: http://www.ildong.com

Basic Information
Total Employees:
Purchase the Ildong Pharm Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Ildong Pharm Co., Ltd. report to view the information.
Registered Capital:
Purchase the Ildong Pharm Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Ildong Pharm Co., Ltd. report to view the information.
Incorporation Date:
August 01, 2016
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
30.6%
Purchase this report to view the information.
20%
Purchase this report to view the information.
2%
Subsidiaries
(주)루텍
(주)유니기획
Ildong Holdings Co.,Ltd.
Company Performance
Financial values in the chart are available after Ildong Pharm Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-8.56%▼
Total Operating Revenue
-8.35%▼
Operating Profit
N/A
EBITDA
23.67%▲
Net Profit/Loss for the Period
N/A
Total Assets
-2.81%▼
Total Equity
44.09%▲
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
-43536%▼
Quick Ratio
-85.59%▼
Cash Ratio
0.03%▲

Similar companies

Cj Cheiljedang Corporation
 
Kt&G Corporation
Amore Pacific Group
 
Samsung Biologics Co., Ltd.
Green Cross Holdings Corporation
 
Yuhan Corporation
Huons Co., Ltd.
 
Daewoong Bio Inc.
Abbott Diagnostics Korea Co.,Ltd.
 
Daewon Pharmaceutical Co.,Ltd.
Merck Advanced Technologies Co.,Ltd.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo